Literature DB >> 8625919

Neuroprotective effect of insulin-like growth factor I in immortalized hypothalamic cells.

M A Sortino1, P L Canonico.   

Abstract

The neuroprotective action of insulin-like growth factor I (IGF-I) was tested in immortalized hypothalamic GT1-7 cells exposed to reduced glutathione depleting agents, which cause oxidative stress and cell death. The extent of cell survival was assessed by either using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide cytotoxicity assay or counting at the fluorescence microscope GT1-7 cells prelabeled with fluorescent dyes selective for viable and dead cells. Treatments with buthionine sulfoximine (500 microns), diethylmaleate (1 mM), and ethacrynic acid (200 microns) caused diffuse GT1-7 cell death (40-60%). Exposure of the same cells to IGF-I (either before or concomitant to the toxic agent, depending on the drug used) significantly prevented neuronal death. This effect was rapid, concentration-dependent, maximal at concentrations of 25-50 ng/ml, and mimicked by IGF-II, fibroblast growth factor, and the potent antioxidant idebenone. In contrast, IGF-I, as well as idebenone, were completely ineffective in antagonizing the toxic effect produced by different concentrations of menadione. In conclusion, the present data demonstrate a protective role for IGF-I against glutathione depleting agents-induced damage in GT1-7 cells suggesting an antioxidant action of this growth factor in hypothalamic neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625919     DOI: 10.1210/endo.137.4.8625919

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1.

Authors:  S A Loddick; N J Rothwell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Therapeutic potential of IGF-I on hippocampal neurogenesis and function during aging.

Authors:  Gustavo R Morel; Micaela López León; Maia Uriarte; Paula C Reggiani; Rodolfo G Goya
Journal:  Neurogenesis (Austin)       Date:  2016-12-20

3.  Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.

Authors:  S A Loddick; X J Liu; Z X Lu; C Liu; D P Behan; D C Chalmers; A C Foster; W W Vale; N Ling; E B De Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 4.  Insulin-like growth factors and their binding proteins: Potential relevance to reproductive physiology.

Authors:  Yasunori Yoshimura
Journal:  Reprod Med Biol       Date:  2003-03-25

Review 5.  The role of the insulin-like growth factors in the central nervous system.

Authors:  A J D'Ercole; P Ye; A S Calikoglu; G Gutierrez-Ospina
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

6.  Insulin-like growth factor-I (IGF-I) inhibits neuronal apoptosis in the developing cerebral cortex in vivo.

Authors:  Rebecca D Hodge; A Joseph D'Ercole; John R O'Kusky
Journal:  Int J Dev Neurosci       Date:  2007-03-24       Impact factor: 2.457

Review 7.  Can the administration of platelet lysates to the brain help treat neurological disorders?

Authors:  Ouada Nebie; Luc Buée; David Blum; Thierry Burnouf
Journal:  Cell Mol Life Sci       Date:  2022-06-24       Impact factor: 9.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.